Scivision Biotech Inc produces medical Hyaluronic Acid using fermentation biotechnology. The company products include Hya-Dermis and Hya-Joint injection, skin care series and health food.

To Announce The Record Date Of Common Stocks
Transferred From The 2nd Domestic Unsecured Convertible
Bond For The First Quarter Of 2025

Announcement Of Board Meeting Approved The
Consolidated Financial Statements For The First Quarter
Of 2025.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Scivision Biotech (1786 TT)

To Announce The Record Date Of Common Stocks Transferred From The 2nd Domestic Unsecured Convertible Bond For The First Quarter Of 2025

Announcement Of Board Meeting Approved The Consolidated Financial Statements For The First Quarter Of 2025.

Announcement Of The Expected Board Meeting Date For The 2025 First Quarter Financial Report Is 2025/05/08

Announcement Of The Adjustment Of Cash Dividend Distribution Ratio

Announcement The Institution Designated To Collect And Deposit For The Third Domestic Unsecured Convertible Corporate Bonds

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)